Abstract:Graphical and Lay Summary This paper introduces a novel pump‐free, high‐throughput organ‐on‐a‐chip platform compatible with automation for large‐scale applications. Utilizing this platform, a gut‐on‐a‐chip model was successfully developed and employed in the evaluation of drug intestinal absorption. The versatility of this platform in simulating various physiological systems suggests its significant potential as a valuable tool for advancing drug development. Organ‐on‐a‐chip technology has shown great potential in disease modeling and drug evaluation. However, traditional organ‐on‐a‐chip devices are mostly pump‐dependent with low throughput, which makes it difficult to leverage their advantages. In this study, we have developed a generic, pump‐free organ‐on‐a‐chip platform consisting of a 32‐unit chip and an adjustable rocker, facilitating high‐throughput dynamic cell culture with straightforward operation. By utilizing the rocker to induce periodic fluid forces, we can achieve fluidic conditions similar to those obtained with traditional pump‐based systems. Through constructing a gut‐on‐a‐chip model, we observed remarkable enhancements in the expression of barrier‐associated proteins and the spatial distribution of differentiated intestinal cells compared to static culture. Furthermore, RNA sequencing analysis unveiled enriched pathways associated with cell proliferation, lipid transport, and drug metabolism, indicating the ability of the platform to mimic critical physiological processes. Additionally, we tested seven drugs that represent a range of high, medium, and low in vivo permeability using this model and found a strong correlation between their Papp values and human Fa, demonstrating the capability of this model for drug absorption evaluation. Our findings highlight the potential of this pump‐free organ‐on‐a‐chip platform as a valuable tool for advancing drug development and enabling personalized medicine.

Intestine-on-a-Chip Microfluidic Model for Efficient in Vitro Screening of Oral Chemotherapeutic Uptake

Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs

Dynamic in vitro intestinal barrier model coupled to chip-based liquid chromatography mass spectrometry for oral bioavailability studies

Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model

An On-Chip Small Intestine–Liver Model for Pharmacokinetic Studies

A versatile, compartmentalised gut-on-a-chip system for pharmacological and toxicological analyses

Integrated microfluidic system for cell co-culture and simulation of drug metabolism

Organoid-derived Duodenum Intestine-Chip for preclinical drug assessment in a human relevant system

Intestinal Cells-on-Chip for Permeability Studies

Head-to-Head Comparison of Caco-2 Transwell and Gut-on-a-Chip Models for Assessing Oral Peptide Formulations

A Biomimetic Human Gut‐on‐a‐Chip for Modeling Drug Metabolism in Intestine

Pharmacokinetic and pharmacodynamic insights from microfluidic intestine-on-a-chip models

Perfusable Vessel-on-a-Chip for Antiangiogenic Drug Screening with Coaxial Bioprinting

An on-chip intestine-liver model for multiple drugs absorption and metabolism behavior simulation

Capturing and Quantifying Particle Transcytosis with Microphysiological Intestine‐on‐Chip Models

Application of a gut–liver-on-a-chip device and mechanistic modelling to the quantitative in vitro pharmacokinetic study of mycophenolate mofetil

A generic pump‐free organ‐on‐a‐chip platform for assessment of intestinal drug absorption

Emerging microfluidic gut-on-a-chip systems for drug development

Development of Gut-Mucus Chip for Intestinal Absorption Study